Kymos is a CRO that provides development services for pharmaceutical, biotechnology, veterinary, fine chemistry, cosmetics and nutraceuticals industries. The main areas of activity are the following ones:
i) Immunogenicity studies and immunoassay of innovative biological drugs, biosimilars and vaccines.
ii) Bioanalysis in preclinical and clinical studies, including full bioequivalence studies.
iii) Quality control, stability studies and analytical development of drug substances and drug products (physico-chemical and microbiological testing)
iv) Process analytical technology services, using NIR and RAMAN and QbD strategies.
Kymos is certified in GLP's and GMP's compliance and it has been authorized as partial manufacturer in quality control.
Company Details
- Employees
- 213
- Founded
- -
- Address
- Parc Tecnològic Del Vallès, Ronda Can Fatjó 7b,spain
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- kymos.es
- Keywords
- Bioanalysis of preclinical and clinical studies, Quality Control of ingredients and products, Batch release certifications, Pharmaceutical development, Immunogenicity, Immunoassay, Bioequivalence studies.
- HQ
- Cerdanyola del Vallès, Barcelona
Kymos Group Questions
Kymos Group's website is kymos.es
Kymos Group's LinkedIn profile is https://es.linkedin.com/company/kymos-group
Kymos Group has
213 employees.
View email and phone details for 213
employees at Kymos Group.
Kymos Group's industry is
Pharmaceutical Manufacturing
Kymos Group's top competitors are
Esteve,
Grifols,
Almirall,
Reig Jofre,
Kern Pharma,
Anapharm Bioanalytics,
Ferrer,
Neuraxpharm,
Asphalion,
Pharmaprogress S.r.l..
Kymos Group's categories are Pharmaceutical Manufacturing
Kymos Group's founding year is 2001
